0001021561-20-000077.txt : 20201215 0001021561-20-000077.hdr.sgml : 20201215 20201215170904 ACCESSION NUMBER: 0001021561-20-000077 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201215 FILED AS OF DATE: 20201215 DATE AS OF CHANGE: 20201215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NAPIERSKI RYAN S CENTRAL INDEX KEY: 0001652984 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12421 FILM NUMBER: 201390306 MAIL ADDRESS: STREET 1: C/O NU SKIN ENTERPRISES INC STREET 2: 75 WEST CENTER STREEET CITY: PROVO STATE: UT ZIP: 84601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NU SKIN ENTERPRISES, INC. CENTRAL INDEX KEY: 0001021561 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 870565309 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 BUSINESS PHONE: 801-345-1000 MAIL ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ENTERPRISES INC DATE OF NAME CHANGE: 19980909 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ASIA PACIFIC INC DATE OF NAME CHANGE: 19960919 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-12-15 0001021561 NU SKIN ENTERPRISES, INC. NUS 0001652984 NAPIERSKI RYAN S C/O NU SKIN ENTERPRISES, INC. 75 WEST CENTER STREET PROVO UT 84601 0 1 0 0 President Class A Common Stock 2020-12-07 5 G 0 3000 0 D 78500 D Class A Common Stock 2020-12-15 4 M 0 7000 30.63 A 85500 D Class A Common Stock 2020-12-15 4 S 0 7000 50.97 D 78500 D Employee Stock Option (Right to Buy) 30.63 2020-12-15 4 M 0 7000 0 D 2023-03-02 Class A Common Stock 7000 77800 D Sale pursuant to a 10b5-1 plan adopted by the Reporting Person. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $50.85 to $51.21, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price within this range. Currently exercisable in full. /s/ Gregory Belliston as Attorney-in-Fact for Ryan S. Napierski 2020-12-15